BamSEC and AlphaSense Join Forces
Learn More

Lisata Therapeutics Inc. – Transcripts

NASDAQ: LSTA    
Share price (3/27/26): $5.02    
Market cap (3/27/26): $45.3 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Earnings Revised 01/15/26 Lisata Therapeutics, Inc., Q3 2025 Earnings Call, Nov 06, 2025 11/06/25 Earnings Revised 08/07/25 Lisata Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 08/07/25 Earnings Revised 05/09/25 Lisata Therapeutics, Inc., Q1 2025 Earnings Call, May 08, 2025 05/08/25 Earnings Revised 03/10/25 Lisata Therapeutics, Inc., 2024 Earnings Call, Feb 27, 2025 02/27/25
CY 2024
Earnings Revised 01/02/25 Lisata Therapeutics, Inc., Q3 2024 Earnings Call, Nov 12, 2024 11/12/24 Earnings Revised 08/12/24 Lisata Therapeutics, Inc., Q2 2024 Earnings Call, Aug 12, 2024 08/12/24 Earnings Revised 05/09/24 Lisata Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 05/09/24 Other Revised 04/26/24 Lisata Therapeutics, Inc. - Special Call 04/10/24 Earnings Revised 02/29/24 Lisata Therapeutics, Inc., 2023 Earnings Call, Feb 29, 2024 02/29/24
CY 2023
Earnings Revised 01/18/24 Lisata Therapeutics, Inc., Q3 2023 Earnings Call, Nov 02, 2023 11/02/23 Earnings Revised 08/15/23 Lisata Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023 08/15/23 Other Revised 02/08/24 Lisata Therapeutics, Inc. - Special Call 06/21/23 Earnings Revised 05/10/23 Lisata Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023 05/09/23 Earnings Revised 03/30/23 Lisata Therapeutics, Inc., Q4 2022 Earnings Call, Mar 30, 2023 03/30/23
CY 2022
Earnings Revised 11/10/22 Lisata Therapeutics, Inc., Q3 2022 Earnings Call, Nov 10, 2022 11/10/22 Other Revised 08/14/22 Caladrius Biosciences, Inc. - Special Call 08/14/22 Earnings Revised 08/04/22 Caladrius Biosciences, Inc., Q2 2022 Earnings Call, Aug 04, 2022 08/04/22 Other Revised 05/24/22 Caladrius Biosciences, Inc. - Special Call 05/24/22 Earnings Revised 05/05/22 Caladrius Biosciences, Inc., Q1 2022 Earnings Call, May 05, 2022 05/05/22 Other Revised 04/27/22 Caladrius Biosciences, Inc., Cend Therapeutics Inc. - M&A Call 04/27/22 Earnings Revised 03/22/22 Caladrius Biosciences, Inc., Q4 2021 Earnings Call, Mar 22, 2022 03/22/22
CY 2021
Earnings Revised 11/04/21 Caladrius Biosciences, Inc., Q3 2021 Earnings Call, Nov 04, 2021 11/04/21 Earnings Revised 08/05/21 Caladrius Biosciences, Inc., Q2 2021 Earnings Call, Aug 05, 2021 08/05/21 Earnings Revised 05/06/21 Caladrius Biosciences, Inc., Q1 2021 Earnings Call, May 06, 2021 05/06/21 Earnings Revised 02/25/21 Caladrius Biosciences, Inc., Q4 2020 Earnings Call, Feb 25, 2021 02/25/21
CY 2020
Earnings Revised 11/05/20 Caladrius Biosciences, Inc., Q3 2020 Earnings Call, Nov 05, 2020 11/05/20 Earnings Revised 08/13/20 Caladrius Biosciences, Inc., Q2 2020 Earnings Call, Aug 13, 2020 08/13/20 Other Revised 06/18/20 Caladrius Biosciences, Inc. - Shareholder/Analyst Call 06/18/20 Earnings Revised 05/07/20 Caladrius Biosciences, Inc., Q1 2020 Earnings Call, May 07, 2020 05/07/20 Earnings Revised 03/05/20 Caladrius Biosciences, Inc., Q4 2019 Earnings Call, Mar 05, 2020 03/05/20
CY 2019
Earnings Revised 11/06/19 Caladrius Biosciences, Inc., Q3 2019 Earnings Call, Nov 06, 2019 11/06/19 Earnings Revised 08/08/19 Caladrius Biosciences, Inc., Q2 2019 Earnings Call, Aug 08, 2019 08/08/19 Earnings Revised 05/09/19 Caladrius Biosciences, Inc., Q1 2019 Earnings Call, May 09, 2019 05/09/19 Earnings Revised 03/14/19 Caladrius Biosciences, Inc., Q4 2018 Earnings Call, Mar 14, 2019 03/14/19
CY 2018
Earnings Revised 11/08/18 Caladrius Biosciences, Inc., Q3 2018 Earnings Call, Nov 08, 2018 11/08/18